SRFM Earnings

SRFM reported its earnings on 2026-03-12, showcasing a revenue of 26.45M against an estimate of 26.42M, resulting in a 0.11% surprise. The EPS was -0.16, surpassing the expected -0.3 by 46.67%. The stock experienced a -22.34% price change on the earnings day and a -25.53% change over the next five days, reflecting market reactions to the results.

Following SRFM's earnings announcement on 2026-03-12, the stock price moved by -22.34% on the day of the release. Over the subsequent five days, it saw a -25.53% change. Historically, SRFM's stock price tends to shift by an average of 1.37% in the 10 days leading up to earnings and -23.42% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SRFM's annual revenue to reach 27.30M, while the EPS is projected at -0.29. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SRFM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SRFM's stock price typically moves by 1.37% in the 10 days before its earnings and -23.42% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.29 and revenue of 27.30M.

The earnings call reveals significant financial challenges, including declining margins, increased losses, and a reduced cash position. Despite some positive developments in product enhancements and future margin expectations, the immediate financial outlook remains weak. The Q&A session highlights concerns about unclear management responses and ongoing investments impacting profitability. The raised 2025 revenue guidance and strategic financing efforts are positive, but they are overshadowed by the current financial struggles and lack of clear guidance on expense reductions. Overall, the sentiment leans negative due to the financial difficulties and uncertainties.